drugset / Trial / NCT00036062
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether sivelestat will reduce the amount of time a patient must spend on a ventilator and/or increase the chance of survival of patients with acute lung injury.
Timeline
- Start
- 2001-08
- Primary completion
- —
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sivelestat | Small molecule | — | — |